urmila

163 POSTS 0 COMMENTS

Philips completes acquisition of Spectranetics

Philips has announced that it has completed the acquisition of The Spectranetics Corporation, a US-based global leader in vascular intervention and lead management solutions....

Dexamethasone treatment prevents TACE side-effects in hepatocellular carcinoma patients

A randomised, double-blind, placebo-controlled trial evaluating the efficacy of prophylactic dexamethasone in preventing the most frequent adverse events of transcatheter arterial chemoembolization (TACE) in...

ASTER trial finds “no increased rate of revascularisation” with stent retriever...

The ASTER randomised clinical trial that examined the effect of endovascular contact aspiration vs. stent retriever on revascularisation in patients with acute ischaemic stroke...

Lutonix registry data confirm durability of drug-coated balloon treatment in superficial...

The 24-month results of the worldwide experience with Lutonix 035 drug-coated balloon (CR Bard/Beckton Dickenson) were published online in August in JACC: Cardiovascular Interventions....

Single and double needle ultrasound-guided irrigation have a place in treatment...

According to a new study published online in the journal Radiology, when ultrasound-guided percutaneous irrigation is performed to treat shoulder calcification, the choice of...

Same day Y-90 treatment could become paradigm of the future

While further refining where radioembolization should optimally lie in current treatment paradigms for the most common liver-confined or liver-dominant cancers is important, a honing...

New study uses cryoablation to target vagus nerve and obesity

A new study is underway at Emory Healthcare, Atlanta, USA, to evaluate the use of cryoablation to treat mild to moderate obesity. The clinical trial,...

Gore Viatorr TIPS Endoprosthesis with Controlled Expansion may reduce portal hypertension...

The Gore Viatorr TIPS endoprosthesis with Controlled Expansion, a new device configuration developed by Gore, may reduce portal hypertension treatment complications, even when compared...

Johnson and Johnson announces new neurovascular business, Cerenovus

Johnson and Johnson Medical Devices Companies introduced Cerenovus, its new neurovascular business, at the Society of NeuroInterventional Surgery 14th Annual Meeting (SNIS; 24–28 July,...

Spectranetics announces FDA approval of Stellarex drug-coated balloon

Spectranetics has announced receipt of US Food and Drug Administration (FDA) premarket approval of the Stellarex drug-coated balloon (DCB), designed to restore and maintain...

SIR issues position statement encouraging paid parental leave

The Society of Interventional Radiology and its Women in Interventional Radiology section have issued a position statement to support interventional radiologists who choose to...

Update for CIRSE’s European IR Curriculum and Syllabus

The Cardiovascular and Interventional Radiological Society of Europe (CIRSE) has announced the presentation of the second edition of the European Curriculum and Syllabus for...

Stephen Solomon assumes Society of Interventional Oncology presidency

The Society of Interventional Oncology (SIO) has announced new officers and a Board of Directors. Stephen Solomon, chief of Interventional Radiology at Memorial Sloan Kettering...

Gore announces first TEVAR with Gore Tag conformable thoracic stent graft...

Gore has announced the first patient implant of conformable thoracic stent graft with Active Control System after receiving CE mark last month. The first...

Journal of Vascular and Interventional Radiology has growing impact on medicine

The Journal of Vascular and Interventional Radiology’s (JVIR’s) impact factor—one measure of a journal’s influence based on the number of article citations compared to...

BIOFLEX-1 pivotal trial results demonstrate safety and efficacy of Pulsar-18 stent...

Biotronik has announced that 12-month data from the BIOFLEX-I study have demonstrated the safety and efficacy of the company’s Pulsar-18 self-expanding stent for blocked...

Right-side survival data from SIRFLOX/FOXFIRE global studies presented at WCGIC

Sirtex has announced the presentation of the SIRFLOX/FOXFIRE Global right-side survival data in metastatic colorectal cancer at the 19th European Society for Medical Oncology...

Early data finds image-guided ablation “feasible and well tolerated” for oligometastatic...

A retrospective review of single-institution experience, published in July in the Journal of Vascular and Interventional Radiology (JVIR), suggests that percutaneous image-guided ablation is...

Radiofrequency ablation used to treat cancer pain for patients

Interventional radiologists at the Emory Johns Creek Hospitals (EJCH), Johns Creek, USA, are using radiofrequency ablation to reduce pain for cancer patients. Radiofrequency ablation is...

Philips acquires CardioProlific

Royal Philips has announced the acquisition of CardioProlific Inc, a USA-based, privately-held company that is developing catheter-based thrombectomy approaches to treat peripheral vascular disease. Financial...

Augmenix announces first prostate cancer patients treated with SpaceOAR hydrogel in...

Augmenix, a medical technology company that develops, manufactures, and sells proprietary absorbable hydrogels that separate and protect organs at risk during radiotherapy and interventional...

Philips sets sights on Spectranetics, also acquires CardioProlific

Royal Philips and The Spectranetics Corporation announced that they have entered into a definitive merger agreement. Pursuant to the agreement, Philips will commence a...

Embosphere receives US FDA de novo classification for prostatic artery embolization

Merit Medical has announced that it has received 513(f)(2) (de novo) classification from the FDA to expand indication for its Embosphere microspheres. The indication...

Argon Medical formalises Medical Advisory Board

Argon Medical announced in June that it has formalised a Medical Advisory Board comprised of distinguished physicians from institutions across the USA who specialise...

WCIO session highlights the pick of recent interventional oncology research

A session at the World Conference on Interventional Oncology (WCIO; 8–11 June, Boston, USA), organised by the Society of Interventional Oncology (SIO), identified the...

ACCESS PTS study demonstrates Ekos’ efficacy in treatment of post-thrombotic syndrome

BTG has highlighted the results of the ACCESS PTS trial, presented at the Society for Vascular Medicine 28th annual scientific sessions (14–17 June, New...

Twelve-month NEAT trial data promising for everlinQ endoAVF haemodialysis access system

TVA Medical has announced the online publication of positive results from the Novel Endovascular Access Trial (NEAT) evaluating its everlinQ endoAVF system. The 12-month...

Inauguration of the first Infinix-i 4D CT in Europe

The Montpellier University Hospital (Montpellier, France) has inaugurated an avant-garde interventional radiology intervention room in the Department of Interventional Radiology at the St-Eloi Hospital....

Study suggests uterine fibroid embolization helps restore fertility

The treatment can help restore fertility in women with uterine fibroids, according to a new study published online in the journal Radiology. Uterine fibroids are...

SIO announces first grants in interventional oncology /immuno-oncology research programme

The Society of Interventional Oncology (SIO and BTG have announced their 2017 Interventional interventional oncology /immuno-oncology research grant recipients. The interventional oncology /immuno-oncology research programme...

IN.PACT Admiral approved for reimbursement in France and Belgium

Medtronic has announced recent reimbursement approvals in both France and Belgium. A Ministerial decree was published in the Official Journal of French Republic to enlist...

Pioneer Plus catheter re-entry device with intravascular ultrasound guidance relaunched

Philips has announced the relaunch of the Pioneer Plus catheter, described as the only re-entry device with intravascular ultrasound (IVUS) capabilities and needle deployment...

SIRveNIB abstract published by ASCO, to be presented on 4 June

SIRveNIB is an investigator-led Asia Pacific Primary Liver Cancer Study to be presented on 4 June 2017 at the American Society of Clinical Oncology...

Adept Medical launches I.R Platform

Adept Medical, the Auckland based manufacturer of the STARSystem, has announced the release of its latest product innovation, the I.R. Platform (interventional radiology platform)....

First patient enrolled in IN.PACT arteriovenous access drug-coated balloon study

The US FDA has approved the investigational device exemption (IDE) study to evaluate the safety and efficacy of IN.PACT AV access drug-coated balloon as...

REsect study shows SIRT makes metastatic colorectal cancer patients more likely...

Metastatic colorectal cancer patients treated first-line with SIR-spheres Y-90 resin microspheres more likely to become candidates for potentially curative liver surgery, the REsect study...

New data show SIRT does not prolong overall survival in metastatic...

The FOXFIRE, SIRFLOX and FOXFIRE Global randomised studies evaluated the efficacy of combining first-line chemotherapy for metastatic colorectal cancer with selective internal radiotherapy (SIRT)...

Medtronic gets option to purchase QT Vascular’s non-drug coated Chocolate PTA

QT Vascular has announced that it has entered into an asset purchase option agreement with Medtronic, for the acquisition of the non-drug coated Chocolate...

High radiation dose to operator with prostatic artery embolization, until imaging...

According to our results, the physician who performs prostatic artery embolization procedures, even with a ceiling suspended shield, would reach the annual radiation limit...

Interrupting inflammatory signals decreases repeat artery blockage in peripheral arterial disease...

Peripheral artery disease patients who were treated with an anti-inflammatory steroid injected directly into the tissue surrounding their leg artery showed a significant reduction...

CIRA appoints Daniel Lapointe as new executive director

The Canadian Interventional Radiology Association (CIRA) Board of Directors has announced the appointment of Daniel Lapointe as CIRA’s new executive director on the association’s...

German Federal Institute for Drugs and Medical Devices approves new indication...

Guerbet has announced that the Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM; The German Federal Institute for Drugs and Medical Devices) has now approved Lipiodol...

Consistent results for Medtronic IN.PACT Admiral in complex peripheral artery disease...

Two new sub-analyses from the IN.PACT Global Study of the IN.PACT Admiral in patients with peripheral artery disease have been reported at the annual...

Positive results for Boston Scientific Ranger paclitaxel-coated PTA balloon catheter

Positive results from the RANGER SFA trial for Boston Scientific’s Ranger paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter have been presented at the 2017...

BD to acquire Bard for US$24 billion

BD (Becton, Dickinson and company) has definitively agreed to acquire Bard for US$317 per common share in cash and stock, for a total consideration...

SIRT significantly better tolerated than sorafenib, but does not increase overall...

The 459-patient randomised controlled SARAH study shows that local treatments of advanced or inoperable hepatocellular carcinoma with selective internal radiation therapy (SIRT) did not...

Getinge launches the new Advanta V12 32mm balloon expandable covered stent

Getinge is proud to announce the launch of the Advanta V12 32mm length balloon expandable covered stent at the Charing Cross International Conference. This...

First European patients treated with DC Bead Lumi radiopaque drug-eluting beads

Two patients were treated for hepatocellular carcinoma and one patient was treated for malignant colorectal cancer metastasised to the liver. DC Bead Lumi is...

PAIRS meeting showcases interventional radiology trends in the Middle East

The 2017 edition of the annual PAIRS meeting was held in Dubai 15–18 March and reflected the growing enthusiasm of the interventional radiology community...

Merit showcases new generation radial compression device

Merit has showcased a new radial compression product, Preludesync, on its website. The Preludesync devices assists in achieving vascular haemostasis. It features a large area...

Medical Groups unite in support of science in the USA

The Society of Interventional Radiology (SIR), the American Society of Hematology and 23 other medical societies have released a statement in support of the...

Women with fibroids see significant improvement in sexual function one year...

A study published online ahead of print in CardioVascular and Interventional Radiology (CVIR) has demonstrated that at one year, uterine fibroid embolization significantly improves...

Identification of pancreatic cancer pathway could broach new era of effective...

Pancreatic Cancer Action Network (PanCAN) grantee George Miller, head of the Cancer Immunology Program at Perlmutter and vice chair for research in the Department...

First US patient treated in vascular study of Lithoplasty technology

PinnacleHealth CardioVascular Institute has enrolled the first US patient in a trial assessing the safety and effectiveness of a new type of approach for...

Codman Neuro acquires Neuravi

Codman Neuro has announced the acquisition of Neuravi. This acquisition comes after the company’s recent acquisition of Pulsar Vascular, expanding its products for stroke...

Ivolution now available in 200mm length devices

Ivascular has announced the product range extension of its self-expandable stent, iVolution, to 200mm length, in various diameters. Ivolution is a nitinol endovascular stent, combining...

UK Medical announces ‘strategic buy out’ from BD

A Sheffield healthcare company has announced a strategic ‘buy out’ from its parent company, BD (Becton, Dickinson and Company), a deal which will see...

Terumo announces first commercial clinical case using Quiremspheres

Terumo Europe NV has announced the first commercial clinical case using Quiremspheres—the next generation radioembolization microspheres for advanced unresectable liver cancer. Quiremspheres are the only...

Study suggests adenomatous-dominant benign prostatic hyperplasia could predict successful embolization

A study recently published in Cardiovascular and Interventional Radiology has, for the first time, identified adenomatous-dominant benign prostatic hyperplasia as a predictor of clinical...

Cryoablation allows safe and effective local control of breast cancer

“Cryoablation of metastatic breast cancer is a safe and effective method that allows local control of the disease,” Claudio Pusceddu told delegates at the...

Hitting cancer with high-intensity ultrasound and immunotherapy

In a new study published in JCI Insight, UC Davis researchers have shown that combining high-intensity focused ultrasound with two immunotherapies (a PD-1 checkpoint...

Solero microwave ablation system gets CE mark

Angiodynamics has announced it has received CE mark certification for the Solero microwave tissue ablation system. Solero and its accessories are indicated for the...

Mirabilis announces European approval for non-invasive uterine fibroid treatment

Mirabilis has announced CE mark authorisation to market the Mirabilis System in the European Union. The system combines high-speed therapeutic ultrasound technology with an...

Metactive announces issuance of patents on Blockstent and Ballstent embolization devices

Metactive, an early-stage company focused on developing embolization devices for the treatment of peripheral vascular and neurovascular diseases, has announced the issuance of US...

New meta-analysis supports RenalGuard use in cardiovascular interventional procedures

  The new meta-analysis, presented as a poster by researchers from the University of Texas Health Sciences Center, San Antonio, USA, during the 2017 American...

Siemens Healthineers introduces innovations in ultrasound guidance and liver embolization

The new Acuson Freestyle Elite ultrasound system can now be combined with the Artis angiography systems to enable fast and easy-to-use ultrasound guidance during...

Randomised trial finds no difference in changes between MS patients who...

Venoplasty is not effective in treating multiple sclerosis, according to the first presentation of interim data from a randomised, double blind clinical trial of...

Artificial intelligence virtual consultant could guide interventional radiology patient care

Interventional radiologists at the University of California at Los Angeles (UCLA), Los Angeles, USA, are using technology found in self-driving cars to power a...

1,000-patient study indicates prostate artery embolization remains effective for years

Prostate artery embolization maintains its effectiveness for at least three years after patients undergo the therapy, according to research presented at the Society of...

Bluegrass Vascular announces strategic relationship with Merit Medical

Bluegrass Vascular has announced that it is entering into a strategic relationship with Merit Medical. The agreement will streamline European distribution of the recently...

ATTRACT fails to meet primary endpoint, but experts agree results are...

Data from the randomised controlled ATTRACT trial revealed that the addition of catheter-based intervention to standard-of-care anticoagulation failed to significantly decrease the occurrence of...

US study suggests fibroid embolization “vastly underutilised” compared with hysterectomy

A large US nationwide study shows that the uterine fibroid embolization is vastly underutilised, compared to hysterectomy—especially in rural and smaller hospitals. In fact, there...

Innovative catheter-based treatment offers relief to children with frequent migraines

A minimally invasive treatment for migraine headaches used for adults is also proving to be a safe and effective treatment for children and teenagers....

Interventional oncology should identify “unmet immunotherapy needs”

Daniel Sze, speaking at the ninth annual Symposium on Clinical Interventional Oncology (CIO; 4–5 February 2017, Hollywood, USA), noted that immunotherapy is a “huge...

Thailand FDA approves new indication for Guerbet’s Lipiodol Ultra-Fluide

Guerbet has announced that the Thailand FDA has given approval of a new indication for Lipiodol Ultra-Fluide for selective hepatic intra-arterial injection for visualisation,...

Surefire closes US$12.8 million funding, to present new data at SIR

Surefire, the developer of site-specific delivery devices for the interventional oncology market, has announced the first closing of a US$12.8 M Series D financing...

Mentice releases world’s first endovascular simulation training software module for prostatic...

Mentice has announced the release of the world’s first simulation training software module for prostatic artery embolization. The software, created from real patients’ data,...

Gregory John Slater

"War (as in turf war) is an emotional word because in wars, people get hurt. I believe we truly care about the patients we...

ATTRACT trial results to be presented at SIR 2017 meeting

Suresh Vedantham, professor of Radiology and Surgery, Mallinckrodt Institute of Radiology, Washington University School of Medicine in St Louis, USA, is scheduled to present the...

BTG receives US FDA 510(k) clearance for Ekos control unit 4.0

BTG has announced that US FDA 510(k) clearance has been granted to the Ekos control unit 4.0. The Ekos system includes an ultrasonic device...

Cook Medical announces Universa sets to streamline percutaneous drainage product line

Cook Medical has rounded out the Universa line with the introduction of two new sets for percutaneous urinary drainage. Each set includes a catheter and...

ASTER results support use of Penumbra aspiration as frontline thrombectomy therapy...

Penumbra has announced the presentation of the results of the ASTER trial, the first independent, prospective, randomised trial comparing the use of Penumbra’s aspiration...

Philips launches Azurion worldwide

  Philips has announced the global launch of Azurion, its next generation image-guided therapy platform, which forms the new core of its integrated solutions portfolio...

Adding interventional oncology to immuno-oncology

Some research data suggest there could be a synergistic effect between immunotherapy and minimally invasive procedures. Tumour types that do not respond to checkpoint...

BTG and SIO to explore role of minimally invasive therapies in...

BTG has announced a collaboration with the Society of Interventional Oncology (SIO; a global organisation working to nurture and support interventional oncology worldwide) to...

OsteoCool RF ablation system gets expanded indication for palliative treatment of...

Medtronic has announced that the US FDA has cleared an expanded indication for the OsteoCool radiofrequency (RF) ablation system. Originally cleared for use in the...

Barry Katzen announces new global society for critical limb ischaemia

Barry Katzen, Miami, USA, announced the establishment of a new society, the Critical Limb Ischaemia (CLI) Global Society, whose mission is to improve quality...

DANCE data boost for dexamethasone use after revascularisation in femoropopliteal arteries

While drug-eluting devices, be they balloons or stents, use chemotherapeutic agents (usually paclitaxel) to reduce the build-up of scar tissue inside the arteries, a...

Argon sells critical care platform to Merit

Argon has announced that it has completed the sale of its Critical Care Unit including a manufacturing facility in Yishun, Singapore and related commercial...

Society of Interventional Radiology statement on US president Donald J Trump’s...

Society of Interventional Radiology (SIR) president Charles E Ray Jr has issued the following statement in response to US president Donald J Trump’s executive...

Tom Daschle to address future of healthcare at special SIR 2017...

Former US Senate majority leader Tom Daschle will headline a special 9 March symposium "IR Economics, Quality and Value: Are You Ready For MACRA?"...

Guerbet expands distribution partnership in Canada with Methapharm

Guerbet has announced that as of 1 February 2017, Methapharm will promote and distribute all Guerbet products in Canada. "As a result of our excellent...

US FDA approves first balloon expandable stent graft to treat iliac...

Gore has announced that the Gore Viabahn VBX balloon expandable endoprosthesis has received US FDA approval for treatment of de novo or restenotic lesions...

MAVERRIC to compare microwave ablation to surgery for resectable colorectal liver...

The Karolinska Institute-sponsored, prospective, observational MAVERRIC study aims to demonstrate that a strategy of first line local microwave ablation of colorectal liver metastases is...

SARAH study results to be presented as oral abstract at April...

Sirtex has announced that the SARAH (Sorafenib vs. radioembolisation in advanced hepatocellular carcinoma) randomised controlled study results will be presented at the upcoming European...

TVA Medical presents positive everlinQ endoAVF system results at LINC 2017

TVA Medical has provided clinical updates involving its everlinQ endoAVF system at the 2017 Leipzig Interventional Course (LINC; 24–17 January, Leipzig, Germany). Scientific data were...

Terumo completes acquisition of vascular closure business and other assets of...

Terumo has announced that it has completed its acquisition of certain assets owned by Abbott and St Jude Medical on 20 January 2017 (North...

Lymphatic embolization leads to successful treatment of plastic bronchitis in adults

Researchers who developed a safe and effective procedure to remove thick clogs in children's airways are now reporting similar success in adult patients. In...

Terumo sets sight on Bolton to accelerate growth of vascular graft...

Terumo Corporation has announced that it has entered into a definitive agreement under which it has agreed to acquire Bolton Medical from its parent...

WCIO establishes Society of Interventional Oncology

WCIO has announced via email communication that the board of directors of the organisation, a non-profit association that supports and promotes the field of...

Ulipristal acetate first oral therapy to show positive phase III results...

Ulipristal acetate is the first oral therapy to demonstrate efficacy and safety for uterine fibroids in two US pivotal studies, a press release states. Allergan...

The ESR and CIRSE join forces to promote patient care

The European Society of Radiology (ESR) and the Cardiovascular and Interventional Radiological Society of Europe (CIRSE), have joined forces to address the future of...

First pulmonary embolism patients in Hong Kong treated with the BTG’s...

The first Hong Kong-based patients diagnosed with pulmonary embolism have been treated using the newly available BTG EKOS system. The EKOS system includes an...

Ask4UFE launches #LoveYourUterus campaign

Ask4UFE has announced the #LoveYourUterus campaign to encourage women with painful fibroids to share their stories of health and healing. Uterine fibroids often result...

Teleflex gets US FDA nod for Arrow VPS Rhythm with optional...

Teleflex has announced that its Arrow VPS Rhythm device with optional TipTracker technology has been issued 510(k) clearance so that the device can be...

Abbott completes St Jude Medical acquisition

Abbott announced on 4 January 2017 that it has completed the acquisition of St Jude Medical. “Abbott has a strong track record of successfully integrating...

Canada first country to get DC Bead Lumi treatment for liver...

BTG International Canada has announced the commercial launch of DC Bead Lumi in Canada. The launch represents the first market commercialisation of DC Bead...

New NCCN guidelines recommend SIRT for the treatment of metastatic colorectal...

Sirtex has announced that SIR-Spheres Y-90 resin microspheres have been included as a Category 2A recommended treatment in the latest National Comprehensive Cancer Network...

ConvertX nephroureteral stent system gets US FDA clearance

BrightWater Medical has announced that the US FDA has cleared the company’s innovative ConvertX nephroureteral stent system for treatment of ureteral obstructions. Patients with...

TEVAR’s dirty little secret

“There is no easy fix with current endovascular tools and strategies and a default realisation is that it is easier and more definitive to...

SIRT access “under threat” from commissioning through evaluation process

Selective internal radiation therapy (SIRT) has been available since December 2013 to a defined group of patients with liver metastases in England on the...

Spectranetics gets CE mark for Stellarex 0.014” drug-coated balloon

Spectranetics has announced that its Stellarex 0.014” drug-coated angioplasty balloon has received the CE mark. The device is designed to treat small vessels, below-the...

Final patient enrolled for VIVO iliofemoral venous stent study

Cook Medical has completed enrolment in the first clinical study of an iliofemoral venous stent conducted in the USA under a US FDA-approved investigational device exemption. The...

Merit Medical receives 510(k) clearance for the SwiftNinja steerable microcatheter

Merit Medical Systems has received 510(k) clearance for the  SwiftNinja steerable microcatheter, covering peripheral and coronary applications. With the exception of Japan, Merit has global...

Early data suggest ablation has favourable outcomes for selected small cell...

A preliminary analysis suggests that thermal ablation may be effective in selected patients with local small cell lung cancer without adjuvant therapy. The research...

Twelve-month PARADIGM study data demonstrate benefit of CGuard Embolic Prevention System...

InspireMD has announced 12-month follow up data from PARADIGM-101 study of the CGuard Embolic Prevention System (EPS), which were presented at the Transcatheter Cardiovascular...

Shockwave Medical announces plans for “largest ever” calcified peripheral artery disease...

Shockwave Medical has announced plans for DISRUPT PAD III—what it claims is the “largest ever” multicentre randomised study to exclusively enrol patients with calcified...

US FDA approves TOBA II BTK pivotal IDE clinical study

The US Food and Drug Administration (FDA) has granted staged approval for Intact Vascular’s investigational device exemption (IDE) application to begin its TOBA II...

St Jude Medical shareholders approve merger with Abbott

St Jude Medical has announced that, based on the preliminary voting results from St Jude Medical’s Annual Meeting of Shareholders held on 26 October,...

Medtronic gets FDA clearance of new lower profile HawkOne 6F directional...

Medtronic has received US FDA 510(k) clearance for the HawkOne directional atherectomy system in a new size for treating patients with peripheral artery disease....

Irreversible electroporation has “potential to become new standard of care” in...

A new study presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE 2016, 10–14 September, Barcelona, Spain) meeting finds that the treatment...

3D printing customised vascular stents could minimise complications

Most people have heard about personalised medicine. How about personalised medical devices? Northwestern’s McCormick School of Engineering researchers Guillermo Ameer and Cheng Sun have...

Terumo looks to buy vascular closure and electrophysiology businesses from St...

Abbott and St Jude Medical have announced an agreement in principle to sell certain products to Terumo Corporation.The agreement is an important step toward...

SARAH and SIRveNIB investigators to undertake combined prospective meta-analysis

Liver cancer researchers from France and Singapore collaborate on a prospective meta-analysis of two studies of Y-90 resin microspheres vs. sorafenib in patients with...

BTG and Mirada Medical announce CE mark certification for Simplicit90Y dosimetry...

BTG and Mirada Medical announced CE mark certification for the Simplicit90Y dosimetry software, designed to optimise the planning of Y-90 selective internal radiation therapy...

Percutaneously created arteriovenous fistulae need far fewer post-creation interventions than those...

NEAT (Novel endovascular access trial) data presented at the Vascular Interventional Advances (VIVA) 2016 meeting (18–22 September, Las Vegas, USA) suggest that endovascular arteriovenous...

CORAL data point to large patient group who might benefit from...

Timothy P Murphy, Vascular Disease Research Center, Rhode Island Hospital, Providence, USA, and one of the investigators on the CORAL study, told delegates at...

New ESMO biliary cancer guidelines indicate radioembolization as an option for...

New European Society of Medical Oncology (ESMO) biliary cancer guidelines indicate yttrium-90 (Y-90) therapy as an option for post-chemotherapy treatment of intrahepatic cholangiocarcinoma. Sirtex has announced...

Teleflex receives US FDA clearance for Arrow and TightTrack tunneler

Teleflex has announced that it has received US FDA 510(k) clearance to market its Arrow JACC with Chlorag+ard technology and TightTrack tunneler. Arrow JACC...

First US commercial placements of Angel catheter

Bio2 Medical has announced that the Angel catheter, a new device for the prevention of pulmonary embolism, was placed in two patients at St...

Lumee Oxygen Platform for continuous, real-time monitoring of tissue oxygen receives...

Profusa has announced that receiving the CE mark to market its Lumee Oxygen Platform for continuous, real-time monitoring of tissue oxygen. The company will initially...

Ra Medical receives approval in Europe for Dabra atherectomy system

Ra Medical has announced receiving CE mark approval for the Dabra atherectomy system with catheter. Atherectomy is the removal of the plaque from the arteries,...

Medtronic receives US FDA clearance for TrailBlazer angled peripheral support catheter

Medtronic has announced that the US FDA has cleared the TrailBlazer angled support catheter for use in the peripheral vascular system. Support catheters such...

SOLSTICE preliminary data show cryoablation has “acceptable safety profile” in treatment...

The SOLSTICE clinical study constitutes the largest multicentre, prospective study focused on the clinical use and effectiveness of cryotherapies for patients with primary cancer...

Lutonix Global Real-World Registry 24-month outcomes presented at VIVA 2016

Bard has announced the presentation of the final 24-month results from the Lutonix Global Real-World Registry at the Vascular Intervention Advances (VIVA) 2016 meeting...

Majority of patients treated with embolization for symptomatic fibroids can avoid...

Ten-year outcomes from the randomised controlled EMMY trial were presented at CIRSE 2016 (10–14 September, Barcelona, Spain) by Jim Reekers, Academic Medical Center, Amsterdam,...

Two-year MAJESTIC data show sustained positive results for Eluvia drug-eluting stent

The MAJESTIC trial set out to evaluate the performance of the Eluvia paclitaxel-eluting vascular stent system (Boston Scientific) in the treatment of femoropopliteal artery...

Shockwave announces positive six-month DISRUPT PAD results in patients with calcified...

Shockwave Medical has announced positive clinical results from the pooled DISRUPT PAD study, a single-arm, two-phase, multicentre study evaluating the safety and performance of...

Three-year IN.PACT SFA trial results demonstrate durability, safety and efficacy for...

Medtronic reinforced the durability, consistency, and safety of the IN.PACT Admiral drug-coated balloon in patients with peripheral arterial disease with new data presented in a...

First implant placed in Gore Tag thoracic branch endoprosthesis pivotal study

Gore has announced the placement of the first implant of the Gore Tag thoracic branch endoprosthesis in the pivotal study. The patient was enrolled...

Shockwave Medical Lithoplasty system cleared by the US FDA

Shockwave Medical has announced clearance from the US FDA of the Lithoplasty system for the treatment of calcified plaque in patients with peripheral arterial...

SIRT Users’ Network announces European expansion

The SIRT Users' Network of professionals who treat liver cancer is to extend across the UK, Belgium, Spain and Italy The success of the SIRT Users' Network,...

Philips introduces next generation interventional oncology solution for advanced tumour analysis...

Royal Philips has announced the unveiling of its latest innovation in interventional oncology at the Cardiovascular and Interventional Radiological Society of Europe annual meeting...

CIRSE 2016: Following the beat of modern interventions

See you in Barcelona, September 10-14, for CIRSE 2016 – the world’s largest interventional radiology congress. ...

Gore DrySeal Flex introducer sheath now commercially available

Gore has announced the commercial availability of the Gore DrySeal Flex introducer sheath, after recently gaining clearance for use by regulatory bodies in the...

Bluegrass Vascular gets CE mark approval for Surfacer Inside-Out access catheter...

Bluegrass Vascular has announced receiving CE mark approval for the Surfacer Inside-Out access catheter system, indicated for obtaining central venous access to facilitate catheter...

Revascularisation beats medical management in treatment of intermittent leg claudication

A new study, based on patient-reported outcomes, published online ahead of print on 17 August in JAMA Surgery reports that patients with intermittent claudication...

One-year results of the ILLUMENATE trial show positive results for Stellarex...

Marianne Brodmann, Medical University Graz, Austria, presented the final 12-month results of the ILLUMENATE European randomised clinical trial at the Amputation Prevention Symposium in...

Biopsy after ablation of colorectal metastases “feasible” to identify local progression

Incomplete tumour treatment and local tumour progression remain important limitations to the widespread use of radiofrequency ablation for colorectal liver metastases. This means it...

New documentary titled “Without a Scalpel” to be distributed via video...

The Interventional Initiative, Oakland, USA and Evolve Media Production, San Francisco and New York, USA, have announced the distribution of episode one of the...

BTG announces successful CE mark reclassification for DC Bead to class...

BTG has announced that it has obtained CE mark from the Notified Body British Standards Institution (BSI) following completion of the reclassification of DC...

Substantial growth in ordering of CTA exams in Medicare population

According to a new study by the Harvey L. Neiman Health Policy Institute, the last 13 years have seen a substantial growth in the...

Promising findings for novel drug-eluting peripheral stent

A new animal study, presented at EuroPCR (17–20 May, Paris), indicates that a novel, fluoropolymer-coated, self-expanding, paclitaxel-eluting peripheral stent (Eluvia, Boston Scientific) is associated...

Positioning microwave antenna at least 5mm from heart may reduce cardiac...

Speaking at the World Conference on Interventional Oncology (WCIO; 9–12 June, Boston, USA), George Carberry (University of Wisconsin School of Medicine and Public Health,...

Contego Medical completes enrolment of Paladin clinical registry

Contego Medical has completed enrolment in the Paladin Carotid Post-dilation Balloon System Registry in Europe. The registry involves five centres with 100 patients, and...

AV Medical announces initial US experience with Chameleon angioplasty balloon catheter

AV Medical has announced the commencement of cases in the US with its Chameleon percutaneous transluminal angioplasty balloon catheter. With its Supervision design, Chameleon...

Medtronic gets FDA nod for longer, 150mm length, IN.PACT Admiral drug-coated...

Medtronic has received US FDA approval for the IN.PACT Admiral drug-coated balloon in longer, 150mm, lengths. The new 150mm length balloon, available in four,...

Varithena gets US FDA approval for 30 day post-activation shelf life

BTG has announced that the US FDA has approved an extension of the post-activation shelf life of Varithena (polidocanol injectable foam) 1% to thirty...

European launch of Altura expanded

Lombard Medical has announced that it has expanded the European launch of its new Altura endovascular stent graft system to The Netherlands and Spain....

Major amputation over utilised globally for critical limb ischaemia

Due to an absence of standardised protocols, major amputation is being over utilised worldwide as a treatment for critical limb ischaemia, according to Mary Yost,...

Two year RENOVA randomised data provide boost for stent graft use...

The results from a prospective, randomised study, published online ahead of print in the Journal of Vascular and Interventional Radiology (JVIR) suggest that stent...

Merit Medical pays US$97.5 million to acquire Dfine

Dfine’s products are directed to vertebral augmentation (kyphoplasty and vertebroplasty), as well as targeted radiofrequency ablation of metastatic spinal tumours and these product lines...

SRS Medical gets CE mark approval for Spanner prostate stent

SRS Medical Systems has announced that it has received CE mark approval for use of its Spanner temporary prostate stent in the European Economic...